Enhancing Quality Through GDP Self-Inspections MVS Pharma GmbH

GDP Self-Inspections MVS Pharma GmbH overview: Self-inspections are a cornerstone of the EU Good Distribution Practice (GDP) framework and serve as a key indicator of a mature and effective Quality Management System. Rather than relying solely on external authority inspections, EU GDP requires companies to regularly evaluate their own compliance, identify gaps, and implement corrective actions proactively. At MVS Pharma GmbH, self-inspections are a structured, risk-based activity designed to ensure continuous compliance, operational excellence, and ongoing improvement across all GDP-relevant processes.

EU GDP Expectations for Self-Inspections

EU GDP Chapter 8 requires wholesale distributors to establish a formal self-inspection program covering all aspects of GDP. Self-inspections must be planned, documented, and performed by competent personnel. Identified deficiencies must be evaluated, addressed through corrective and preventive actions (CAPAs), and followed up to ensure effectiveness.

Key GDP expectations include:

• a documented self-inspection procedure
• defined scope and frequency
• qualified and independent inspectors
• documented reports and findings
• CAPA management and follow-up
• management and Responsible Person (RP) oversight

Self-Inspection Program at MVS Pharma GmbH

• Documented and Risk-Based Planning

MVS Pharma operates a documented self-inspection SOP, defining the methodology, responsibilities, and reporting requirements. Self-inspections are planned on an annual basis, with a risk-based approach applied to determine frequency. Critical GDP areas are inspected more frequently, ensuring that higher-risk activities receive enhanced oversight.

• Comprehensive Scope of Inspections

Self-inspections at MVS Pharma cover the full GDP system, including:

• Quality Management System
• Personnel and training
• Premises and equipment
• Documentation control
• Operations (receipt, storage, dispatch)
• Outsourced activities
• Transportation
• Returns, complaints, and recalls

This comprehensive scope ensures that no GDP-relevant activity is excluded from review.

Qualified and Independent Execution

• Competent Inspection Personnel

Self-inspections are performed by the Responsible Person (RP), who is highly qualified and experienced in GDP and GMP requirements. The RP holds formal GDP certification from the ECA Academy and GMP certification from the Berlin BioScience Academy, ensuring inspections are conducted with strong regulatory insight and technical competence.

Where possible, inspections are performed independently of the inspected activity to maintain objectivity.

• Use of Structured Checklists

Self-inspections are conducted using structured checklists aligned with EU GDP requirements. This ensures consistency, completeness, and traceability of inspection activities and supports systematic identification of gaps or improvement opportunities.

Reporting and Classification of Findings

• Documentation of Inspection Results

Each self-inspection results in a formal inspection report documenting:

• inspected areas and activities
• observations and deficiencies
• classification of findings (e.g., critical, major, minor)
• timelines for corrective actions

Reports are reviewed by Quality Management and the RP and are archived under the Digital Quality Management System.

CAPA Management and Follow-Up

• Corrective and Preventive Actions

All identified deficiencies are addressed through documented CAPAs. Root cause analysis is performed to ensure corrective actions address underlying causes rather than symptoms.

CAPAs are tracked to closure, and effectiveness checks are performed to confirm that implemented actions achieve the intended outcome.

Management Review and Continuous Improvement

• Oversight and Trend Analysis

Self-inspection outcomes are reviewed by the RP and discussed during Management Review Meetings (MRM). Trends, recurring findings, and systemic issues are analyzed to drive continuous improvement across the organization.

This ensures that self-inspections contribute directly to strengthening the Quality Management System rather than being a purely compliance-driven activity.

Record Retention and Traceability

• Controlled Documentation

All self-inspection plans, reports, CAPAs, and follow-up records are retained under the Digital QMS in accordance with defined retention requirements. Records are readily retrievable for internal review and regulatory inspections, ensuring full transparency and traceability.

Conclusion

MVS Pharma GmbH is committed to maintaining a proactive, structured, and EU GDP-compliant self-inspection program. Through risk-based planning, qualified execution, comprehensive reporting, and strong Responsible Person and management oversight, self-inspections serve as a key driver of continuous compliance and quality improvement across all GDP activities.

The post Enhancing Quality Through GDP Self-Inspections MVS Pharma GmbH appeared first on MVS Pharma.